Individual trends in LDL-C control in patients with previous myocardial infarction-Reference-Cited by-同舟云学术

Individual trends in LDL-C control in patients with previous myocardial infarction

Published:2020-01 Issue:1 Volume:55 Page:23-29
ISSN:2605-1532
Container-title:REC: CardioClinics
language:en
Short-container-title:REC: CardioClinics

Author:

Ródenas Eduardo,Escalona Roxana,Pariggiano Ivana,Oristrell Gerard,Miranda Berta,Belahnech Yassin,Soriano Toni,Rello Pau,Gordon Blanca,Barrabés José A.,García-Dorado David,Bañeras Jordi

Funder

FEDER

Spanish Health Institute

CIBERCV

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis;Navarese;JAMA,2018

2. Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis;Silverman;JAMA,2016

3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

4. 2016 ESC/EAS guidelines for the management of dyslipidaemias;Catapano;Eur Heart J,2016

5. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines;Grundy;J Am Coll Cardiol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Awareness Among Primary Care Physicians in Canada of Guideline Recommendations for Lowering LDL-Cholesterol in High-Risk Patients;CJC Open;2023-05

2. Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study;Frontiers in Cardiovascular Medicine;2022-08-04

3. Bempedoic acid, an inhibitor of ATP citrate lyase for the treatment of hypercholesterolemia: early indications and potential;Expert Opinion on Investigational Drugs;2020-06-21